| 2D Structure | |
| CID | 246983 |
| Target | / |
| IUPAC Name | (3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol |
| InChI | InChI=1S/C30H50O/c1-20(2)10-9-11-21(3)22-14-18-30(8)24-12-13-25-27(4,5)26(31)16-17-28(25,6)23(24)15-19-29(22,30)7/h10,21-22,25-26,31H,9,11-19H2,1-8H3/t21-,22-,25+,26+,28-,29-,30+/m1/s1 |
| InChI Key | CAHGCLMLTWQZNJ-BQNIITSRSA-N |
| Canonical SMILES | CC(CCC=C(C)C)C1CCC2(C1(CCC3=C2CCC4C3(CCC(C4(C)C)O)C)C)C |
| Isomeric SMILES | C[C@H](CCC=C(C)C)[C@H]1CC[C@@]2([C@@]1(CCC3=C2CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C)C |
| Molecular Formula | C30H50O |
| Molecular Weight | 426.7 |
| synonyms | ['lanosterol', 'Lanosterin', 'Lanster', 'Botalan base 138', 'Lanosta-8,24-dienol', '(3beta)-lanosta-8,24-dien-3-ol', 'Kryptosterol', 'Lanosta-8,24-dien-3beta-ol', 'Lanostereol', 'Botalan base', 'Lanostadien-3-beta-ol', 'CHEBI:16521', 'Lanosta-8,24-dien-3-ol, (3.beta.)-', 'NSC 60677', 'UNII-1J05Z83K3M', 'Lanosta-8,24-dien-3-ol, (3beta)-', 'Lanosta-8,24-dien-3-beta-ol', 'Lanosta-8,24-dien-3.beta.-ol', '1J05Z83K3M', 'LANOSTEROL [MI]', 'EINECS 201-214-9', 'NSC-60677', '(3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol', '(3-beta)-Lanosta-8,24-dien-3-ol', '(3.beta.)-Lanosta-8,24-dien-3-ol', 'BRN 2226449', 'AI3-23643', 'DTXSID1040744', "4,4',14alpha-Trimethyl-5alpha-cholesta-8,24-dien-3beta-ol", 'Lanosta-8,24-dien-3-ol, (3-beta)-', '(3beta,20R)-Lanosta-8,24-dien-3-ol', 'Cholesta-8,24-dien-3-ol, 4,4,14-trimethyl-, (3beta,5alpha)-', 'Cholesta-8,24-dien-3-ol, 4,4,14-trimethyl-, (3.beta.,5.alpha.)-', '(3beta,5alpha)-4,4,14-trimethylcholesta-8,24-dien-3-ol', '4,4,14alpha-trimethyl-5alpha-cholesta-8,24-dien-3beta-ol', '(3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-((2R)-6-methylhept-5-en-2-yl)-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta(a)phenanthren-3-ol', 'LANOSTEROL [INCI]', 'DTXCID9020744', '4,4,14 alpha-trimethyl-5 alpha-cholesta-8,24-dien-3 beta-ol', 'Lanosta-8,24-dien-3beta-ol (8CI)', '201-214-9', '4-06-00-04188 (beilstein handbook reference)', 'cahgclmltwqznj-bqniitsrsa-n', 'cahgclmltwqznj-liyszjhcsa-n', '79-63-0', 'Cryptosterol', 'NSC60677', '8,24-Lanostadien-3beta-ol', '3beta-Hydroxy-8,24-lanostadiene', 'Lanosterol (Technical Grade)', 'lanostcrol', 'Lanososterol', 'MFCD00021108', 'Lanosterol - 90%', 'Lanosta-8, (3.beta.)-', 'Lanosterol, >=93%, powder', 'SCHEMBL145834', 'CHEMBL225111', 'GTPL2746', 'GLXC-14819', 'BDBM50459238', 'LMST01010017', 'MSK164264', 's4755', '(3|A)-Lanosta-8,24-dien-3-ol', '(3 beta)-Lanosta-8,24-dien-3-ol', 'AKOS024307002', 'DB03696', 'FL71051', 'HY-W020033', 'NCGC00164398-01', 'FL159528', 'MS-27534', '1ST164264', 'CS-0031956', 'Lanosterol (Isocholesterol) - Lanosterol 60%', 'C01724', 'A929846', 'Q414996', '(3alpha)-4,4,14-trimethyl-Cholesta-8,24-dien-3-ol', 'C4CA2F34-1C1A-4673-AC43-E547708CB228', 'Cholesta-8, 4,4,14-trimethyl-, (3.beta.,5.alpha.)-', '(3beta,5alpha)-4,4,14-trimethyl-Cholesta-8,24-dien-3-ol', '8,24-Lanostadiene-3?-ol;Isocholesterol;3?-Hydroxy-8,24-lanostadiene', '(3S,5R,10S,13R,14R,17R)-17-[(1R)-1,5-dimethylhex-4-enyl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol'] |
From Pubchem